Clinical Trial Update: AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating allogeneic stem cell transplantation with alpha/beta T cell and CD19+ B cell depletion for malignant and non-malignant hemat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amegakaryocytic Thrombocytopenia
• Aplastic Anemia
• Beta-thalassemia
• Diamond-blackfan Anemia
• Hodgkin Lymphoma
• Kostmann Syndrome
• Leukemia
• Non-hodgkin Lymphoma
• Sickle Cell Disease

Snippet

Sponsor: Mitchell Cairo | Conditions: Acute Leukemia, Severe Aplastic Anemia | Phase 2 | Status: RECRUITING